Literature DB >> 27804971

RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features.

V I Gaidzik, V Teleanu, E Papaemmanuil, D Weber, P Paschka, J Hahn, T Wallrabenstein, B Kolbinger, C H Köhne, H A Horst, P Brossart, G Held, A Kündgen, M Ringhoffer, K Götze, M Rummel, M Gerstung, P Campbell, J M Kraus, H A Kestler, F Thol, M Heuser, B Schlegelberger, A Ganser, L Bullinger, R F Schlenk, K Döhner, H Döhner.   

Abstract

Entities:  

Year:  2016        PMID： 27804971     DOI： 10.1038/leu.2016.207

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  19 in total

1.  Only SETBP1 hotspot mutations are associated with refractory disease in myeloid malignancies.

Authors:  Nils Winkelmann; Vivien Schäfer; Jenny Rinke; Alexander Kaiser; Philipp Ernst; Sebastian Scholl; Andreas Hochhaus; Thomas Ernst
Journal:  J Cancer Res Clin Oncol       Date:  2017-09-14       Impact factor: 4.553

2.  Genetic regulation of the RUNX transcription factor family has antitumor effects.

Authors:  Ken Morita; Kensho Suzuki; Shintaro Maeda; Akihiko Matsuo; Yoshihide Mitsuda; Chieko Tokushige; Gengo Kashiwazaki; Junichi Taniguchi; Rina Maeda; Mina Noura; Masahiro Hirata; Tatsuki Kataoka; Ayaka Yano; Yoshimi Yamada; Hiroki Kiyose; Mayu Tokumasu; Hidemasa Matsuo; Sunao Tanaka; Yasushi Okuno; Manabu Muto; Kazuhito Naka; Kosei Ito; Toshio Kitamura; Yasufumi Kaneda; Paul P Liu; Toshikazu Bando; Souichi Adachi; Hiroshi Sugiyama; Yasuhiko Kamikubo
Journal:  J Clin Invest       Date:  2017-05-22       Impact factor: 14.808

3.  Paradoxical enhancement of leukemogenesis in acute myeloid leukemia with moderately attenuated RUNX1 expressions.

Authors:  Ken Morita; Shintaro Maeda; Kensho Suzuki; Hiroki Kiyose; Junichi Taniguchi; Pu Paul Liu; Hiroshi Sugiyama; Souichi Adachi; Yasuhiko Kamikubo
Journal:  Blood Adv       Date:  2017-08-08

Review 4.  Classification and risk assessment in AML: integrating cytogenetics and molecular profiling.

Authors:  Matahi Moarii; Elli Papaemmanuil
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

5.  PRKCH regulates hematopoietic stem cell function and predicts poor prognosis in acute myeloid leukemia.

Authors:  Shaina N Porter; Jeffrey A Magee
Journal:  Exp Hematol       Date:  2017-06-06       Impact factor: 3.084

6.  Recurrent somatic JAK-STAT pathway variants within a RUNX1-mutated pedigree.

Authors:  Kiran Tawana; Jun Wang; Péter A Király; Krisztián Kállay; Gábor Benyó; Marianna Zombori; Judit Csomor; Ahad Al Seraihi; Ana Rio-Machin; András Matolcsy; Claude Chelala; Jamie Cavenagh; Jude Fitzgibbon; Csaba Bödör
Journal:  Eur J Hum Genet       Date:  2017-05-17       Impact factor: 4.246

7.  Born to RUNX1.

Authors:  Pamela J Sung; Daria V Babushok
Journal:  Blood       Date:  2020-05-21       Impact factor: 25.476

Review 8.  RUNX1 Mutations in Inherited and Sporadic Leukemia.

Authors:  Dana C Bellissimo; Nancy A Speck
Journal:  Front Cell Dev Biol       Date:  2017-12-20

9.  Clinical Outcomes and Co-Occurring Mutations in Patients with RUNX1-Mutated Acute Myeloid Leukemia.

Authors:  Maliha Khan; Jorge Cortes; Tapan Kadia; Kiran Naqvi; Mark Brandt; Sherry Pierce; Keyur P Patel; Gautam Borthakur; Farhad Ravandi; Marina Konopleva; Steven Kornblau; Hagop Kantarjian; Kapil Bhalla; Courtney D DiNardo
Journal:  Int J Mol Sci       Date:  2017-07-26       Impact factor: 5.923

10.  Comparison of mutational profiles and clinical outcomes in patients with acute myeloid leukemia with mutated RUNX1 versus acute myeloid leukemia with myelodysplasia-related changes with mutated RUNX1.

Authors:  Lynh Nguyen; Xiaohui Zhang; Evans Roberts; Seongseok Yun; Kathy McGraw; Ivo Abraham; Jinming Song; Diana Braswell; Dahui Qin; David A Sallman; Jeffrey E Lancet; Alan F List; Lynn C Moscinski; Eric Padron; Ling Zhang
Journal:  Leuk Lymphoma       Date:  2020-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.